A phase 2 trial of cetuximab for patients with locally advanced/metastatic chordoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Anthony Paul Conley, J. Andrew Livingston, Carlos Torrado, Vinod Ravi, Shaan Raza, Laurence D. Rhines, Andrew Justin Bishop, Amol J. Ghia, David R. Grosshans, Wei-Lien Wang, Alexander J. Lazar, Justin E. Bird, Christopher Alvarez-Breckenridge, Bryan Moon, Claudio Tatsui, Gregory Michael Cote, Josh Sommer, Daniel M. Freed, Neeta Somaiah, Shreyaskumar Patel
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Chordoma Foundation
OpenAlex ID: W7162551062
Cites:
Cited by:
Related to: